Honeywell launches authentication tech to prevent counterfeit pharma drugs

Honeywell on Monday announced digital authentication technology for the pharmaceutical industry in response to the growing menace of counterfeit products.

An acute shortage of drugs to treat symptoms of Covid-19 has led to increased circulation of counterfeit medicines in recent times, a company statement said.

It added that there are reports of fake antiviral medicines and spurious injectable immunosuppressants in the market.

With rising demand for vaccines, there is concern that fake vaccines could find their way into circulation.

Earlier this year, the World Health Organisation sounded an alarm over criminal exploitation of an unmet global demand for Covid-19 vaccines.